Medartis cancels convertible bond despite sweetening terms
![A skull with titanium plates of Medartis, a Swiss producer of metal implants for the surgical management of fractures, is seen during a news conference to present the planned IPO, in Zurich, Switzerland March 12, 2018. REUTERS/Moritz Hager](https://assets.euromoneydigital.com/dims4/default/dbb2a70/2147483647/strip/true/crop/5096x3408+0+0/resize/840x562!/quality/90/?url=http%3A%2F%2Feuromoney-brightspot.s3.amazonaws.com%2F37%2F4a%2F58e304ab44e89766dad96f9f3bef%2F2cn37t2-1.jpg)
'Aggressive' pricing fails to attract investors
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
The content you are trying to view is exclusive to our subscribers.
To unlock this article: